Advertisement
Screener

Eagle Health Investments LP Historic Quarter Change: USA Stocks, New

Add as a preferred source on Google

Eagle Health Investments LP historic quarter change: USA Stocks, New

In share positions in stocks (listed in the US), over 10 quarters from 2023-12-31 to 2026-06-30, Eagle Health Investments LP opened 39 positions, added to 48, reduced 58 and sold out of 34.

  • Q2 2026: Stock ASND; Country of operation —; Class ORD SHS; Shares before 0.
  • Q2 2026: Stock AXSM; Country of operation United States; Class COM; Shares before 0.
  • Q2 2026: Stock IONS; Country of operation United States; Class COM; Shares before 0.
  • Q2 2026: Stock DNTH; Country of operation United States; Class COM; Shares before 0.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1842545), 10 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-08-10); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-06); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-07); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-12); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-12); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-12); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-12); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-13); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2020-12-31.

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q2 2026ASND
ASCENDIS PHARMA A/S		ORD SHS0106,158+106,158$0$28,314,462+$28,314,4622026-08-10
Q2 2026AXSM
AXSOME THERAPEUTICS INC.		United StatesCOM065,051+65,051$0$15,922,533+$15,922,5332026-08-10
Q2 2026IONS
IONIS PHARMACEUTICALS INC		United StatesCOM0194,577+194,577$0$15,428,010+$15,428,0102026-08-10
Q2 2026DNTH
DIANTHUS THERAPEUTICS INC		United StatesCOM0131,344+131,344$0$12,803,413+$12,803,4132026-08-10
Q2 2026AVTX
AVALO THERAPEUTICS INC		United StatesCOM NEW0235,093+235,093$0$4,344,519+$4,344,5192026-08-10
Q2 2026LLY
ELI LILLY & CO		United StatesCOM01,994+1,994$0$2,391,663+$2,391,6632026-08-10
Q1 2026RARE
ULTRAGENYX PHARMACEUTICAL IN		United StatesCOM0884,121+884,121$0$18,522,335+$18,522,3352026-05-15
Q1 2026BSX
BOSTON SCIENTIFIC CORP		United StatesCOM0293,152+293,152$0$18,395,288+$18,395,2882026-05-15
Q1 2026TEM
TEMPUS AI INC		United StatesCL A0256,269+256,269$0$11,588,484+$11,588,4842026-05-15
Q1 2026ATAI
ATAIBECKLEY INC		United StatesCOM SHS01,709,359+1,709,359$0$6,051,131+$6,051,1312026-05-15
Q1 2026PCSC
PERCEPTIVE CAP SOLUTIONS COR		CL A ORD SHS037,686+37,686$0$413,415+$413,4152026-05-15
Q4 2025TERN
TERNS PHARMACEUTICALS INC		United StatesCOM0275,090+275,090$0$11,113,636+$11,113,6362026-02-06
Q4 2025KYMR
KYMERA THERAPEUTICS INC		United StatesCOM0136,300+136,300$0$10,605,503+$10,605,5032026-02-06
Q4 2025RVMD
REVOLUTION MEDICINES INC		United StatesCOM0115,900+115,900$0$9,231,435+$9,231,4352026-02-06
Q4 2025SLNO
SOLENO THERAPEUTICS INC		United StatesCOM0135,100+135,100$0$6,255,130+$6,255,1302026-02-06
Q4 2025PTGX
PROTAGONIST THERAPEUTICS INC		United StatesCOM057,300+57,300$0$5,004,582+$5,004,5822026-02-06
Q4 2025QURE
UNIQURE NV		SHS0205,247+205,247$0$4,911,561+$4,911,5612026-02-06
Q4 2025PRAX
PRAXIS PRECISION MEDICINES I		United StatesCOM NEW014,951+14,951$0$4,406,658+$4,406,6582026-02-06
Q4 2025MLTX
MOONLAKE IMMUNOTHERAPEUTICS		SwitzerlandCLASS A ORD0187,600+187,600$0$2,472,568+$2,472,5682026-02-06
Q4 2025IRON
DISC MEDICINE INC		United StatesCOM027,100+27,100$0$2,152,011+$2,152,0112026-02-06
Q3 2025FTRE
FORTREA HLDGS INC		United StatesCOMMON STOCK0988,772+988,772$0$8,325,460+$8,325,4602025-11-07
Q3 2025ALKS
ALKERMES PLC		SHS081,800+81,800$0$2,454,000+$2,454,0002025-11-07
Q2 2025UNH
UNITEDHEALTH GROUP INC		United StatesCOM060,888+60,888$0$18,995,229+$18,995,2292025-08-12
Q2 2025BBIO
BRIDGEBIO PHARMA INC		United StatesCOM0259,300+259,300$0$11,196,574+$11,196,5742025-08-12
Q2 2025GH
GUARDANT HEALTH INC		United StatesCOM0212,000+212,000$0$11,032,480+$11,032,4802025-08-12
Q2 2025SRRK
SCHOLAR ROCK HLDG CORP		United StatesCOM0269,400+269,400$0$9,542,148+$9,542,1482025-08-12
Q1 2025EXAS
EXACT SCIENCES CORP		United StatesCOM0388,650+388,650$0$16,824,659+$16,824,6592025-05-12
Q1 2025AKRO
AKERO THERAPEUTICS INC		United StatesCOM0226,400+226,400$0$9,164,672+$9,164,6722025-05-12
Q1 2025VIR
VIR BIOTECHNOLOGY INC		United StatesCOM0240,500+240,500$0$1,558,440+$1,558,4402025-05-12
Q3 2024NBIX
NEUROCRINE BIOSCIENCES INC		United StatesCOM0128,600+128,600$0$14,817,292+$14,817,2922024-11-12
Q2 2024UNH
UNITEDHEALTH GROUP INC		United StatesCOM086,900+86,900$0$44,254,694+$44,254,6942024-08-13
Q2 2024INSM
INSMED INC		United StatesCOM PAR $.010513,700+513,700$0$34,417,900+$34,417,9002024-08-13
Q2 2024BMRN
BIOMARIN PHARMACEUTICAL INC		United StatesCOM0231,800+231,800$0$19,084,094+$19,084,0942024-08-13
Q2 2024GRAL
GRAIL INC		United StatesCOM053,124+53,124$0$816,516+$816,5162024-08-13
Q1 2024RARE
ULTRAGENYX PHARMACEUTICAL IN		United StatesCOM0299,700+299,700$0$13,992,993+$13,992,9932024-05-14
Q1 2024EXAS
EXACT SCIENCES CORP		United StatesCOM0121,000+121,000$0$8,356,260+$8,356,2602024-05-14
Q1 2024TXG
10X GENOMICS INC		United StatesCL A COM0135,059+135,059$0$5,068,764+$5,068,7642024-05-14
Q1 2024HOWL
WEREWOLF THERAPEUTICS INC		United StatesCOM0700,000+700,000$0$4,536,000+$4,536,0002024-05-14
Q1 2024VKTX
VIKING THERAPEUTICS INC		United StatesCOM045,000+45,000$0$3,690,000+$3,690,0002024-05-14

Similar Firms

Firm NameCountry13F ValueHoldings
Nordwand Advisors, LLCUnited States$0.572B150
FOX RUN MANAGEMENT, L.L.C.United States$0.572B856
McLean Asset Management CorpUnited States$0.572B165
Marble Wealth, LLCUnited States$0.571B222
Black Swift Group, LLCUnited States$0.571B117
Ironwood Financial, llcUnited States$0.573B168
Drucker Wealth 3.0, LLCUnited States$0.573B522
RPTC Inc.United States$0.571B7
XXEC, Inc.United States$0.571B23
Tulsa Wealth Advisors, INCUnited States$0.570B150
Advertisement